查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2060239

電腦輔助檢測市場分析及預測（至2035年）：類型、產品類型、技術、組件、應用、部署模式、最終用戶、功能、解決方案、方法

Computer-Aided Detection Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Deployment, End User, Functionality, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球電腦輔助檢測（CAD）市場預計將從2025年的9億美元成長到2035年的15億美元，年複合成長率（CAGR）為4.9%。電腦輔助診斷（CAD）市場集中度適中，在腫瘤學領域，尤其是在乳癌和肺癌檢測方面，需求強勁。人工智慧和機器學習在醫學影像診斷中的日益普及是推動該市場成長的主要因素。醫院和診斷中心正依靠CAD系統來提高診斷準確率。領先企業正致力於將CAD與影像診斷系統和醫療IT平台進行整合。策略聯盟和收購正在推動技術進步。慢性病盛行率的上升和對早期診斷需求的不斷成長將繼續促進該市場的成長。

電腦輔助診斷 (CAD) 市場按類型分類，其中乳房X光CAD系統佔據市場主導地位，該系統在乳癌早期檢測中發揮著至關重要的作用。由於乳癌發病率不斷上升以及對準確可靠診斷解決方案的需求日益成長，這些系統正在醫療機構中廣泛應用。肺癌CAD系統也呈現顯著成長，這得益於肺癌發生率的上升以及影像技術的不斷進步。此外，人工智慧 (AI) 的整合顯著提高了診斷準確性，從而加速了CAD系統的普及應用。

市場區隔
種類 乳癌篩檢、肺癌篩檢、大腸癌篩檢、攝護腺癌篩檢、肝癌篩檢等。
產品 軟體、服務、整合解決方案及其他
科技 深度學習、機器學習、自然語言處理、影像識別、模式辨識等。
成分 硬體、軟體、服務及其他
目的 腫瘤科、循環系統、神經科、整形外科及其他科室
實作方法 雲端部署、本地部署、混合部署及其他
最終用戶 醫院、診斷中心、研究機構、學術機構及其他
功能 影像分析、資料管理、工作流程最佳化等等。
解決方案 獨立式、整合式或其他
模式 全自動、半自動、手動、其他

從技術角度來看，基於X光影像的電腦輔助診斷（CAD）系統因其在識別各種疾病（包括骨折和腫瘤）方面的廣泛應用而佔據市場主導地位。同時，基於磁振造影（MRI）的CAD系統憑藉其卓越的成像能力以及在神經系統和肌肉骨骼系統診斷方面不斷擴展的應用，也正經歷著強勁的成長。影像技術的不斷進步和對精準醫療日益成長的關注，持續推動這些技術的應用。

區域概覽

北美電腦輔助檢測 (CAD) 市場高度成熟，這主要得益於醫療領域對先進成像技術和人工智慧 (AI) 的積極應用。美國憑藉對醫療IT基礎設施的大量投資以及放射科對 CAD 系統的廣泛應用，在該市場佔據主導地位。慢性病（尤其是癌症）盛行率的上升，推動了對早期檢測解決方案的需求。加拿大也透過不斷普及數位醫療技術，為市場做出了貢獻。人工智慧和機器學習的持續創新正在提高診斷準確性和工作流程效率，使 CAD 系統成為全部區域現代診斷實踐中不可或缺的一部分。

亞太地區的電腦輔助診斷（CAD）市場正快速擴張，這主要得益於醫療數位化進程的推進以及對先進診斷工具日益成長的需求。中國、日本和印度等國家引領著這一趨勢，這得益於醫療技術和基礎設施投資的不斷增加。慢性病盛行率的上升以及人們對早期診斷意識的增強，推動了CAD技術的應用。政府推廣數位化醫療解決方案的措施也為市場進一步成長提供了支持。醫院網路的擴展和影像技術普及程度的提高，正在加速市場滲透。人工智慧診斷技術的持續進步預計將進​​一步推動全部區域的成長。

主要趨勢和促進因素

人工智慧與機器學習的融合：

電腦輔助檢測 (CAD) 市場正呈現出人工智慧 (AI) 和機器學習技術融合的顯著趨勢。這些進步透過減少假陽性和提高檢測率，提升了診斷影像的準確性和效率。 AI 系統能夠更有效地分析複雜的醫學影像，幫助醫療專業人員及早發現異常。這種融合正在改變診斷工作流程，並改善患者的治療效果。隨著技術的進步，AI 驅動的 CAD 系統有望成為現代醫學診斷中不可或缺的一部分。

對早期診斷的需求日益成長：

對疾病早期檢測日益成長的需求是電腦輔助檢測 (CAD) 市場的主要驅動力。早期診斷能顯著改善治療效果，尤其對於癌症和心血管疾病等疾病。醫療機構正擴大採用 CAD 系統來提高診斷的準確性和效率。患者意識的提高和影像技術的進步進一步推動了這一趨勢。此外，政府為促進預防醫學和篩檢計畫所採取的措施也推動了市場需求。這種對早期檢測的重視正在加速 CAD 解決方案在醫療保健系統中的應用。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 乳癌篩檢
    • 肺癌篩檢
    • 大腸直腸癌篩檢
    • 攝護腺癌篩檢
    • 肝癌篩檢
    • 其他
  • 市場規模及預測：依產品分類
    • 軟體
    • 服務
    • 整合解決方案
    • 其他
  • 市場規模及預測：依技術分類
    • 深度學習
    • 機器學習
    • 自然語言處理
    • 影像識別
    • 模式識別
    • 其他
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務
    • 其他
  • 市場規模及預測：依應用領域分類
    • 腫瘤學
    • 心血管系統
    • 神經病學
    • 整形外科
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷中心
    • 研究機構
    • 學術機構
    • 其他
  • 市場規模及預測：依市場細分
    • 基於雲端的
    • 現場
    • 混合
    • 其他
  • 市場規模及預測：依功能分類
    • 影像分析
    • 資料管理
    • 工作流程最佳化
    • 其他
  • 市場規模及預測：按解決方案分類
    • 獨立版
    • 一體化
    • 其他
  • 市場規模及預測：依檢測方法分類
    • 自動化
    • 半自動
    • 手動的
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • GE Healthcare
  • Hologic
  • Siemens Healthineers
  • Philips Healthcare
  • iCAD Inc
  • Canon Medical Systems
  • Agfa-Gevaert Group
  • Fujifilm Holdings Corporation
  • Zebra Medical Vision
  • NVIDIA Corporation
  • IBM Watson Health
  • Thermo Fisher Scientific
  • Varian Medical Systems
  • Hitachi Medical Systems
  • Esaote SpA
  • Carestream Health
  • Merge Healthcare
  • Riverain Technologies
  • ScreenPoint Medical
  • Qure.ai

第9章 關於我們

簡介目錄
Product Code: GIS26962

The global Computer-Aided Detection Market is projected to grow from $0.9 billion in 2025 to $1.5 billion by 2035, at a compound annual growth rate (CAGR) of 4.9%. The Computer-Aided Detection Market is moderately consolidated, with strong demand in oncology applications, especially breast and lung cancer detection. It is driven by increasing use of AI and machine learning in medical imaging. Hospitals and diagnostic centers rely on CAD systems to improve diagnostic accuracy. Key players focus on integrating CAD with imaging systems and healthcare IT platforms. Strategic partnerships and acquisitions support technological advancements. Rising chronic disease prevalence and demand for early diagnosis continue to drive growth in this market.

The Computer-Aided Detection (CAD) market is segmented by type, with mammography CAD systems holding a dominant position due to their vital role in early breast cancer detection. These systems are widely implemented across healthcare facilities, driven by the increasing prevalence of breast cancer and the growing need for accurate and reliable diagnostic solutions. Lung CAD systems are also witnessing notable growth, supported by the rising incidence of lung cancer and continuous advancements in imaging technologies. Furthermore, the integration of artificial intelligence (AI) is significantly enhancing diagnostic precision and accelerating adoption.

Market Segmentation
TypeBreast Cancer Detection, Lung Cancer Detection, Colorectal Cancer Detection, Prostate Cancer Detection, Liver Cancer Detection, Others
ProductSoftware, Services, Integrated Solutions, Others
TechnologyDeep Learning, Machine Learning, Natural Language Processing, Image Recognition, Pattern Recognition, Others
ComponentHardware, Software, Services, Others
ApplicationOncology, Cardiovascular, Neurology, Orthopedics, Others
DeploymentCloud-Based, On-Premise, Hybrid, Others
End UserHospitals, Diagnostic Centers, Research Institutes, Academic Institutions, Others
FunctionalityImage Analysis, Data Management, Workflow Optimization, Others
SolutionsStandalone, Integrated, Others
ModeAutomated, Semi-Automated, Manual, Others

In terms of technology, X-ray imaging-based CAD systems lead the market owing to their widespread use in identifying multiple conditions, including fractures and tumors. Meanwhile, MRI-based CAD systems are experiencing robust growth due to their superior imaging capabilities and expanding applications in neurological and musculoskeletal diagnostics. Ongoing advancements in imaging modalities and the increasing focus on precision medicine continue to drive the adoption of these technologies.

Geographical Overview

The Computer-Aided Detection market in North America is highly mature, driven by strong adoption of advanced imaging technologies and artificial intelligence in healthcare. The United States dominates due to significant investments in healthcare IT infrastructure and widespread use of CAD systems in radiology. Increasing prevalence of chronic diseases, particularly cancer, is fueling demand for early detection solutions. Canada also contributes with growing adoption of digital health technologies. Continuous innovation in AI and machine learning enhances diagnostic accuracy and workflow efficiency, making CAD systems an integral part of modern diagnostic practices across the region.

The Asia-Pacific CAD market is rapidly expanding due to increasing healthcare digitization and rising demand for advanced diagnostic tools. Countries such as China, Japan, and India are key contributors, supported by growing investments in medical technology and healthcare infrastructure. Rising prevalence of chronic diseases and increasing awareness of early diagnosis are driving adoption. Government initiatives promoting digital healthcare solutions further support growth. Expanding hospital networks and improving access to imaging technologies are enhancing market penetration. Continuous advancements in AI-driven diagnostics are expected to accelerate growth across the region.

Key Trends and Drivers

Integration of AI and Machine Learning:

The computer-aided detection market is witnessing a significant trend toward the integration of artificial intelligence and machine learning technologies. These advancements are improving the accuracy and efficiency of diagnostic imaging by reducing false positives and enhancing detection rates. AI-driven systems can analyze complex medical images more effectively, assisting healthcare professionals in identifying abnormalities at an early stage. This integration is transforming diagnostic workflows and improving patient outcomes. As technology continues to evolve, AI-powered CAD systems are expected to become an essential component in modern healthcare diagnostics.

Increasing Demand for Early Diagnosis:

The growing need for early disease detection is a key driver of the computer-aided detection market. Early diagnosis significantly improves treatment outcomes, particularly in conditions such as cancer and cardiovascular diseases. Healthcare providers are increasingly adopting CAD systems to enhance diagnostic accuracy and efficiency. Rising awareness among patients and advancements in imaging technologies are further supporting adoption. Additionally, government initiatives promoting preventive healthcare and screening programs are boosting demand. This focus on early detection is driving the widespread use of CAD solutions across healthcare systems.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Breast Cancer Detection
    • 4.1.2 Lung Cancer Detection
    • 4.1.3 Colorectal Cancer Detection
    • 4.1.4 Prostate Cancer Detection
    • 4.1.5 Liver Cancer Detection
    • 4.1.6 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software
    • 4.2.2 Services
    • 4.2.3 Integrated Solutions
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Deep Learning
    • 4.3.2 Machine Learning
    • 4.3.3 Natural Language Processing
    • 4.3.4 Image Recognition
    • 4.3.5 Pattern Recognition
    • 4.3.6 Others
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Hardware
    • 4.4.2 Software
    • 4.4.3 Services
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Oncology
    • 4.5.2 Cardiovascular
    • 4.5.3 Neurology
    • 4.5.4 Orthopedics
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Diagnostic Centers
    • 4.6.3 Research Institutes
    • 4.6.4 Academic Institutions
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 Cloud-Based
    • 4.7.2 On-Premise
    • 4.7.3 Hybrid
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Image Analysis
    • 4.8.2 Data Management
    • 4.8.3 Workflow Optimization
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Standalone
    • 4.9.2 Integrated
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Semi-Automated
    • 4.10.3 Manual
    • 4.10.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Deployment
      • 5.2.1.8 Functionality
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Deployment
      • 5.2.2.8 Functionality
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Deployment
      • 5.2.3.8 Functionality
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Deployment
      • 5.3.1.8 Functionality
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Deployment
      • 5.3.2.8 Functionality
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Deployment
      • 5.3.3.8 Functionality
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Deployment
      • 5.4.1.8 Functionality
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Deployment
      • 5.4.2.8 Functionality
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Deployment
      • 5.4.3.8 Functionality
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Deployment
      • 5.4.4.8 Functionality
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Deployment
      • 5.4.5.8 Functionality
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Deployment
      • 5.4.6.8 Functionality
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Deployment
      • 5.4.7.8 Functionality
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Deployment
      • 5.5.1.8 Functionality
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Deployment
      • 5.5.2.8 Functionality
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Deployment
      • 5.5.3.8 Functionality
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Deployment
      • 5.5.4.8 Functionality
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Deployment
      • 5.5.5.8 Functionality
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Deployment
      • 5.5.6.8 Functionality
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Deployment
      • 5.6.1.8 Functionality
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Deployment
      • 5.6.2.8 Functionality
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Deployment
      • 5.6.3.8 Functionality
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Deployment
      • 5.6.4.8 Functionality
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Deployment
      • 5.6.5.8 Functionality
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 GE Healthcare
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Hologic
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Siemens Healthineers
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Philips Healthcare
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 iCAD Inc
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Canon Medical Systems
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Agfa-Gevaert Group
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Fujifilm Holdings Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Zebra Medical Vision
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 NVIDIA Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 IBM Watson Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Thermo Fisher Scientific
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Varian Medical Systems
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Hitachi Medical Systems
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Esaote SpA
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Carestream Health
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Merge Healthcare
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Riverain Technologies
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 ScreenPoint Medical
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Qure.ai
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us